A. Seoudy

Circulating sDPP-4 is increased in obesity and insulin resistance but is not related to systemic metabolic inflammation.

A. Franke, M. Laudes, A. Bosy-Westphal, 2020, The Journal of clinical endocrinology and metabolism.

Gliflozins for the Treatment of Congestive Heart Failure and Renal Failure in Type 2 Diabetes.

M. Laudes, I. Cascorbi, Tim Hollstein, 2021, Deutsches Arzteblatt international.

Circulating sDPP-4 is increased in human subjects with obesity and related metabolic abnormalities and is altered in subjects hospitalized for severe COVID-19 infection

A. Franke, M. Laudes, C. Geisler, 2021 .

Case Report: Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc)

P. Rosenstiel, M. Laudes, S. Rose-John, 2022, Frontiers in Pharmacology.

Frailty in patients undergoing transcatheter aortic valve replacement: prognostic value of the Geriatric Nutritional Risk Index

M. Laudes, T. Puehler, G. Nickenig, 2021, Journal of cachexia, sarcopenia and muscle.

BMI, Alcohol Consumption and Gut Microbiome Species Richness Are Related to Structural and Functional Neurological Abnormalities

A. Franke, M. Laudes, C. Geisler, 2021, Nutrients.

A Prospective Analysis of the Metyrapone Short Test Using Targeted and Untargeted Metabolomics

M. Laudes, C. Geisler, D. Schulte, 2023, Neuroendocrinology.

Effects of lifestyle and associated diseases on serum CC16 suggest complex interactions among metabolism, heart and lungs.

P. Rosenstiel, M. Laudes, C. Geisler, 2023, Journal of advanced research.